ALDA Pharmaceutical Corp. Grants Incentive Stock Options
ALDA Pharmaceuticals Corp. (APH:TSX-V) (the “Company”) announces that it has granted incentive stock options to purchase an aggregate of 512,353 common shares at an exercise price of $0.20 per share to the directors, officers and certain employees of the Company.
(PRWEB) January 30, 2004
ALDA Pharmaceuticals Corp. (APH:TSX-V) (the “Company”) announces that it has granted incentive stock options to purchase an aggregate of 512,353 common shares at an exercise price of $0.20 per share to the directors, officers and certain employees of the Company. The Company has granted further incentive stock options to purchase an aggregate of 40,000 common shares at an exercise price of $0.20 per share to certain consultants of the Company. The options are for a term of two years and expire on January 27, 2006. Options granted to directors, officers and employees of the Company and underlying common shares are subject to a four month hold period from the date of grant in accordance with the policies of the TSX Venture Exchange and applicable securities law. Options granted to consultants of the Company and underlying common shares are subject to a four month hold period from the date of grant in accordance with the policies of the TSX Venture Exchange and a further twelve month hold period in accordance with applicable securities law, pending adoption of the revised Multilateral Instrument 45-102.
Terrance G. Owen, Ph. D., MBA
President, Chief Executive Officer and Director
ALDA Pharmaceuticals Corp.
604-521-8300
Terry@aldapharma. com
Www. aldapharma. com
About ALDA Pharmaceuticals Corp.
ALDA Pharmaceuticals Corp. has developed a family of wide spectrum, non-toxic, biodegradable infection control products based on its patent pending T36™ technology. Its first product, ViralexTM, has been tested on over 100 infectious bacteria, viruses and fungi. ViralexTM is 100% effective in killing them all within 3 minutes, including HIV, Hepatitis B and TB.
Viralex™ has been approved by Health Canada for use as a hospital grade, hard surface disinfectant and by the Canadian Food Inspection Agency for use in restaurants and the food processing industry.
The emergence of SARS, Norwalk Virus and new strains of influenza has increased the market demand for Viralex™ as a highly effective, non-toxic and environmentally friendly disinfectant.
###
.jpg)
